 |
 |
Specially formulated for persons who must limit carbohydrate intake — including those with diabetes |
 |
|
|
No deleterious effect on glucose levels or glycemic control |
|
|
|
No effect on blood pressure |
|
|
|
No sugar, sorbitol or sucrose |
|
|
|
No artificial sweeteners |
|
|
|
No pseudoephedrine (pse) or phenylpropanolamine (ppa) | |
From the Diabetes and Glandular Disease Clinic Study,
San Antonio, Texas
“This study did not detect any deleterious effect of 10 days of dosing with sugar-free COLD-EEZE® lozenges on diabetic control as assessed by fructosamine level, fasting blood glucose level, and home glucose monitoring.”
A single-center, randomized, single-blind placebo-controlled trial was conducted in patients with diabetes to assess the effects of sugar-free COLD-EEZE® tablets on glucose control in patients maintained on stable antidiabetic therapy.
Patients:
|
48 persons with Type 1 or Type 2 diabetes were treated with COLD-EEZE® sugar-free zinc or placebo tablets for relief of cold symptoms. |
|
|
|
13 persons received sugar-free placebo tablets. |
|
|
|
35 persons received sugar-free COLD-EEZE® tablets. |
Measures:
Fasting blood glucose level was measured at baseline, study day 10, and study day 21.
Results:
No detrimental effect on overall diabetic control.
Adverse Events:
No patients withdrew from the trial.
There were no serious adverse events.
COLD-EEZE® Sugar-Free Tablets:
|
Each box contains 48 Zinc Gluconate Glycine (ZIGG™) tablets. |
|
|
|
Each tablet contains 4.3 mg of Ionic Zinc. |
|
|
|
Flavor: Unflavored/unsweetened. |
|
|
|
Recommended daily dose: One tablet per hour, maximum of 16 daily. |
|
|
|
Clinically proven to be safe for people with diabetes. |
|
|
|
Contains 0 carbohydrates, 0 calories. |
